NCT06946498 First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.
| NCT ID | NCT06946498 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National and Kapodistrian University of Athens |
| Condition | Suspected Malignant Lung Neoplasm |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-05-23 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-05-23 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Non randomized study with two groups. The study group includes patients with suspected malignant pleural effusion, in whom the investigation of pleural effusion begins directly with pleural biopsy by Local Anesthesia Thoracoscopy (LAT). The Control Group includes patients who come to the same hospital and are treated with the Standard of Care (SOC) strategies were used. Efficacy of LAT, Sensitivity, Hospitalization, time to diagnosis and general safety and comfort of the groups' subjects will be assessed.
Eligibility Criteria
Inclusion Criteria: * Undiagnosed pleural effusion with the character of a lymphocytic exudate Exclusion Criteria: * Empyema * Transudate pleural effusion. * Central airway obstruction by tumor. * Existence of extensive adhesions that do not allow the development of iatrogenic pneumothorax and the safe entry of the thoracoscope. * Uncontrollable cough. * Acute respiratory failure and/or Hypercapnia. * Performance Status: 5
Contact & Investigator
Grigorios Stratakos, Professor
STUDY DIRECTOR
National and Kapodistrian University of Athens
Frequently Asked Questions
Who can join the NCT06946498 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Suspected Malignant Lung Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06946498 currently recruiting?
Yes, NCT06946498 is actively recruiting participants. Contact the research team at aris.anag@yahoo.gr for enrollment information.
Where is the NCT06946498 trial being conducted?
This trial is being conducted at Athens, Greece.
Who is sponsoring the NCT06946498 clinical trial?
NCT06946498 is sponsored by National and Kapodistrian University of Athens. The principal investigator is Grigorios Stratakos, Professor at National and Kapodistrian University of Athens. The trial plans to enroll 100 participants.